Lab Notes: Cabaletta Bio gets FDA nod to advance new drug; South Jersey firm raises $3.5M

This week's roundup of life sciences news from across the Philadelphia region includes updates from Durin Technologies, NRx Pharmaceuticals, Cabaletta Bio and the Children's Hospital of Philadelphia.